Clinical consequences of aspirin and clopidogrel resistance: an overview. - Wikidata - awgldk - TriplyDB

Clinical consequences of aspirin and clopidogrel resistance: an overview.

Clinical consequences of aspirin and clopidogrel resistance: an overview.

http://www.wikidata.org/entity/Q38083817

about

Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.RETRACTED: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis Antiplatelet resistance and the role of associated variables in stable patients treated with stenting.Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study.Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications.Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance.Higher ratio of ischemic stroke to hemorrhagic stroke in summer.Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.

P2860

Q34513880-70A89D32-C218-43D7-93AA-9863B7B7B099 Q35061792-DE86E11D-E180-4775-B865-11A9CF991B3A Q35214494-8BECEC7F-DCAC-4FB7-8A9A-1189CE45F9A5 Q36219096-9143F194-E41F-48E2-A471-CF5B304BBFF3 Q36342136-72176458-34C0-433A-863A-EF0FCB33102E Q38540055-185394FB-1575-4BB4-94F6-B52B5A44527D Q41533636-CE043701-FE6F-4675-82D1-FB4F1DF1A6B7 Q42706087-B322C19A-BDE1-4C2C-BF0B-4228345D460B Q44044731-CC3CDDFB-EBEC-4490-B525-09E22C65C4B3 Q45824389-ACE797D2-9B7D-4BB1-A674-5B6470F8F7C6

P2860

Clinical consequences of aspirin and clopidogrel resistance: an overview.

http://www.wikidata.org/entity/Q38083817

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical consequences of aspirin and clopidogrel resistance: an overview.

@en

type

label

Clinical consequences of aspirin and clopidogrel resistance: an overview.

@en

prefLabel

Clinical consequences of aspirin and clopidogrel resistance: an overview.

@en

P1433

Q38083817-303B782E-1748-44E5-A732-AFAC5DB58D92

P1476

Q38083817-64EA723E-0870-4BEE-B38D-DD6565DF0846

P2093

Q38083817-19199FB9-1546-4A1C-8CEA-48396CA1024B

Q38083817-41A9F32A-818B-4AFF-967B-1C5D7F413BCC

Q38083817-6880A596-C5BB-4636-B293-B99620957266

Q38083817-A625A9BD-5285-46C3-8D20-E512655E21F5

Q38083817-A7F3AE17-3397-4E85-8335-4C03689EF668

Q38083817-FA95DD00-D5A4-4754-8B5C-D5DBB7379267

P2860

Q38083817-04AB539A-BE43-4C91-A990-EE552F68D964

Q38083817-0D6E66ED-70A2-4C4D-BA5F-6AD9E5361243

Q38083817-2768768B-E9C6-43EF-83AF-4A79DF0C3DDB

Q38083817-290A5BE7-A168-4AD5-A166-1E159FC52EDA

Q38083817-2B6D64AC-4291-43DF-B923-4C197CF08762

Q38083817-2BB226D6-CAE2-4E8A-90FB-344A5232764D

Q38083817-2CA1C695-34B6-4DE1-9EE5-7FCDF0C819F9

Q38083817-2EF24702-D479-4EA4-9037-3CD5AA9273C0

Q38083817-2F2288D9-36EB-4818-80A5-335EE243A2BF

Q38083817-321C41C6-42DB-4627-A2B4-DD5BD31C1881

P304

Q38083817-68557F65-51DA-421D-A4D6-CA6F8AF8760A

P31

Q38083817-AB8F1BEB-096A-4D52-B2C9-3EA377B66A4A

P356

Q38083817-E82FC8C2-341D-4241-9EEC-6E6975BEB931

P407

Q38083817-336BE78B-509F-4F3A-B12A-2DC2C7B775DD

P433

Q38083817-5B5379BE-8632-468C-B5BE-85D1B26CF5C2

P478

Q38083817-01F17060-F54C-41F7-B192-D7D2867643A5

P577

Q38083817-F09A078D-1950-4969-BDE6-AF0536F9FED3

P698

Q38083817-2BC28CAF-E98D-4151-A198-A0EC4F0DC693

P921

Q38083817-599B242F-7255-4C3B-870F-953584B7E0FA

P356

P1433

Acta Neurologica Scandinavica

P1476

Clinical consequences of aspirin and clopidogrel resistance: an overview.

@en

P2093

M D Mijajlovic

http://www.w3.org/2001/XMLSchema#string

N Covickovic-Sternic

http://www.w3.org/2001/XMLSchema#string

N M Bornstein

http://www.w3.org/2001/XMLSchema#string

O Shulga

http://www.w3.org/2001/XMLSchema#string

S Bloch

http://www.w3.org/2001/XMLSchema#string

V Aleksic

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction

The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin

Aspirin and clopidogrel resistance: an emerging clinical entity

Aspirin resistance in secondary stroke prevention

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance

P304

213-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12111

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23432706

http://www.w3.org/2001/XMLSchema#string

P921